Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Study of ARO-AAT in Normal Adult Volunteers
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Clinical study
0
Allocation Type
Randomized
0
Health Conditions in Trial
Alpha 1-antitrypsin deficiency
0
Intervention Model
Parallel Assignment
0
Intervention Name
Sterile Normal Saline (0.9% NaCl)
0
ARO-AAT Injection
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Other
0
Drug
0
Last Updated
August 18, 2020
0
Masked Party
Participant
0
Investigator
0
Masking Type
Double
0
Primary Completion Date
October 23, 2018
0
Trial Recruitment Size
45
0
Trial Sponsor
Arrowhead Pharmaceuticals
0
Clinical Trial Start Date
March 12, 2018
0
Study Completion Date
March 21, 2020
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT03362242
0
Official Name
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effect of ARO-AAT on Serum Alpha-1 Antitrypsin Levels in Normal Adult Volunteers
0
Official Website
clinicaltrials.gov/study...362242
0
Find more entities like Study of ARO-AAT in Normal Adult Volunteers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE